The trajectory of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the patent expiration in key territories has introduced considerable volatility. Investors are now grappling with the impact of generi